Segment Information - Schedule of Segment Reporting (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Net revenues - External	$ 4,619,473	$ 3,338,425
(Loss) income from operations	(16,076,107)	(22,491,907)
Depreciation and amortization	1,715,321	2,415,048
Capital expenditures	1,422,002	14,123
Total assets	6,290,794	6,482,393
Clinical Laboratory Operations [Member]
Net revenues - External	2,793,089	3,338,425
(Loss) income from operations	(4,672,768)	(12,946,144)
Depreciation and amortization	1,639,954	2,412,040
Capital expenditures		14,123
Total assets	1,503,520	4,637,984
Hospital Operations [Member]
Net revenues - External	1,826,384
(Loss) income from operations	(4,800,539)
Depreciation and amortization	73,985
Capital expenditures	1,422,002
Total assets	2,549,504
Corporate [Member]
(Loss) income from operations	(6,602,800)	(9,545,763)
Depreciation and amortization	1,382	3,008
Total assets	3,436,773	2,130,191
Assets of AMSG Classified As Held For Sale[Member]
Total assets	255,566	821,449
Eliminations [Member]
Total assets	$ (1,454,570)	$ (1,107,231)